- The regulated content and labeling software firm has made three new customer-facing appointments and created a brand-new Customer Experience Team to provide enhanced, end-to-end customer support for medical device and clinical trial organizations.
- Chief Executive Richard Adams says the creation of the new team reflects the company’s desire to improve the hands-on advice and assistance it can offer to its customers in an increasingly complex and fast-changing market and regulatory environment.
Wokingham – 13 July 2021 – Regulated content and labeling software firm PRISYM ID has announced it is creating a new Customer Experience Team to improve the ongoing advice and support it offers to medical device and clinical trial organizations using its platforms.
Andy McLaughlin, who was previously a Project Director at PRISYM ID, and Jaimie Konetchy, formerly Senior Label Designer for DePuy (part of Johnson and Johnson’s Medical Devices and Diagnostic division), have been appointed in the company’s first Customer Experience roles.
The new Customer Experience Team will work closely with PRISYM ID’s consulting, delivery and support teams to ensure customers receive a high quality, end-to-end service and have a conduit through which they can provide feedback and connect with the full range of advice and technical support available.
In addition, Sue Hastings has been appointed as a Senior Support Analyst within PRISYM ID’s Global Support Team. Sue has 20 years’ experience working in various technology roles, including supporting both Oracle and MS SQL server database applications, and will further enhance PRISYM ID’s business support offer.
Chief Executive Richard Adams said that the appointments and creation of the new team reflected PRISYM ID’s desire to invest significantly in the customer experience at a time when customers are experiencing significant pressures and changes to their operating environments:
“Our experience working with some of the largest organizations across the medical device and clinical trial industries tells us that implementing a labeling solution is not the end of the story. Achieving best value requires a continuous dialogue that enables us to shape our platforms to meet their evolving business needs.
“Whether it is a medical device company coming to terms with regulatory changes or a clinical trial organization adapting to the new world of decentralized trials, we want our customer to feel that they can call upon our expertise at any time to help them get the most out of the products we offer.
“These new appointments, and the creation of our new Customer Experience Team, are all about helping us maintain an ongoing and productive conversation with our customers. It will mean we can learn, adapt and improve our offer in a way that flexes around their changing needs and hence makes the biggest possible contribution to their business.”